Nortriptilina Tecnifar (Nortriptyline)

Nortriptyline blocks the reuptake of the neurotransmitters norepinephrine and serotonin, increasing their concentrations in the synaptic cleft. It also antagonises muscarinic, histamine H1 and alpha‑adrenergic receptors, which together modulate mood pathways, reduce pain signalling, and produce sedative effects.

The appropriate dose of Nortriptilina Tecnafar is individualized by the prescribing clinician based on the patient’s diagnosis, severity of symptoms, age, renal and hepatic function, and response to therapy. No fixed regimen is provided here; the prescriber sets the dosage.

Safety data for nortriptyline in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any potential risk to the fetus or infant. Clinicians should discuss risks with the patient and consider alternative therapies when possible.

To request Nortriptilina Tecnafar, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nortriptilina Tecnafar belongs to the tricyclic antidepressant class, which differs from selective serotonin reuptake inhibitors (SSRIs) and serotonin‑norepinephrine reuptake inhibitors (SNRIs) in its broader receptor profile. TCAs often have stronger anticholinergic and sedative effects, which can be advantageous for certain pain conditions but may increase side‑effect burden compared with newer agents.

Store Nortriptilina Tecnafar at ambient temperature, preferably below 25 °C. Keep the tablets in the original container, protect them from moisture and direct light, and ensure the packaging remains sealed until use.

Nortriptilina Tecnafar is taken orally, usually with or without food, as directed by the prescriber. Tablets should be swallowed whole with a glass of water; they are not intended for crushing, chewing, or sublingual administration.

Serious risks include cardiac arrhythmias, especially in patients with pre‑existing heart disease or in overdose situations, seizures in susceptible individuals, and severe hypotension that can cause dizziness or fainting. Prompt medical attention is required if any of these events occur.

Nortriptilina Tecnafar should be avoided in patients with known hypersensitivity to nortriptyline or other tricyclic antidepressants, those taking monoamine‑oxidase inhibitors within the past 14 days, and individuals with uncontrolled narrow‑angle glaucoma, severe cardiac conduction disorders, or recent myocardial infarction unless specifically directed by a specialist.